HPV vaccine Court cases starting in Japan

Predictably, that is if you had followed CANCERactive’s commentary on HPV vaccines from the outset rather than the Junk Science peddled by the pro-vaccine lobby, you will not be surprised to hear the court claims are now starting to be filed.

More than 60 young women with an average age of 18 have filed in various courts in Japan against the vaccine makers and Health bodies that ‘approved’ the HPV vaccines including the Government.

Vaccination of girls over the age of 11 using Cervical cancer vaccines Cervarix and Gardasil started in April 2013, but within two months the Japanese Government reversed its recommendations after excessive numbers of problems and side-effects.

However, recently new moves were being made by Paediatric Health Organisations to reintroduce the blanket vaccination schemes. This prompted lawyers and injured parties to become more vociferous.

We have detailed the side-effects and inadequate research studies on Junk Science UK before, plus the blind faith of certain key people in UK Health Organisations and even pro-Pharma cancer charities like Cancer Research UK. Over 12,000 adverse cases have been recorded, including death, following such vaccinations.

There were even pro-Pharma activists suggesting all boys needed such vaccinations when clearly boys have different biochemical pathways to girls, and no research had been conducted whatsoever.

, , , , , , , , , , ,

HPV vaccine linked to deaths

A 2012 study published in the journal Pharmaceutical Regulatory Affairs concludes that viral components contained in the human papillomavirus (HPV) vaccine Gardasil can cross the blood-brain barrier and trigger cerebral vasculitis, a severe form of blood vessel inflammation in the brain that can lead to severe autoimmune disorders and even death.

A postmortem assessment of two young girls from opposite ends of the world who died recently after being given the Gardasil vaccine revealed fragments of the HPV-16L1 antigen (which is added to both Gardasil from Merck & Co. and Cervarix from GlaxoSmithKline) inside the girls’ brain tissue. According to the researchers, these particles represent a genetic fingerprint of the Gardasil vaccine. Thus Gardasil may well cause serious, adverse events in at least some of the girls that receive it.

For their research, Dr. Chris Shaw from the University of British Columbia (UBC) in Canada and Dr. Lucija Tomljenovic from the Neural Dynamics Research Group in Vancouver examined samples of brain tissue taken from both girls, one 19 years old and the other 14 years old. Their analysis focused specifically on the potential presence of both HPV-16L1 and HPV-18L1, two specific antigens used in HPV vaccines.

Much to their surprise, the researchers observed that HPV-16L1 had bound itself to the walls of cerebral blood vessels in both of the girls’ brains. They also found inflammation and immune response to these particles. Clearly the viral components of Gardasil had crossed the blood-brain barrier and provoked a serious reaction.

“Our IHC (immunohistochemistry) analysis showed evidence of an autoimmune vasculitis potentially triggered by the cross-reactive HPV-16L1 antibodies binding to the wall of cerebral blood vessels in all examined brain samples,” says the study. “Our study suggests that HPV vaccines containing HPV-16L1 antigens pose an inherent risk for triggering potentially fatal autoimmune vasculopathies.”

According to the vaccine awareness group SaneVax, this is the first time a vaccine has been directly linked to a serious, adverse event. Gardasil to date has been linked to at least 27,485 adverse events, and at least 121 deaths.

“For the average medical consumer, this evidence suggests that the antibodies produced in response to vaccination with the HPV-16L1 may cause one’s immune system to attack its own blood vessels,” wrote Norma Erickson, President of SaneVax, in a recent announcement about the study. “Given that the autopsy in both cases revealed no major abnormality (anatomically, microbiologically or toxicologically) that might have been regarded as a potential cause of death, it appears plausible that the antigenic component of the HPV vaccine (HPV-16L1) was indeed responsible for the fatal inflammation of the blood vessels.” (http://sanevax.org; www.naturalnews.com)

http://www.canceractive.com/cancer-active-page-link.aspx?n=2044

, , , , , , , , , , , , , , , , ,